Polyene Antifungal
Nystatin
The FDA lists this product in 59 strengths and forms.
Indications
Nystatin cream is indicated in the treatment of cutaneous or mucocutaneous mycotic infections caused by Candida albicans and other susceptible Candida species. This cream is not indicated for systemic, oral, intravaginal or ophthalmic use.
Contraindications
Nystatin cream is contraindicated in patients with a history of hypersensitivity to any of their components.
Adverse reactions
The frequency of adverse events reported in patients using nystatin cream is less than 0.1%. The more common events that were reported include allergic reactions, burning, itching, rash, eczema, and pain on application. (See PRECAUTIONS: General. )
Composition
- Active ingredients
- NYSTATIN 100,000 UNITS/GM
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- NYSTATIN 100,000 UNITS/GM · PowderANDA208581-001 · Prescription
- NYSTATIN 100,000 UNITS/GM · PowderANDA208838-001 · Prescription
- NYSTATIN 100,000 UNITS/GM · CreamANDA219527-001 · Prescription
- NYSTATIN 500,000 UNITS · TabletANDA062525-001 · Discontinued
- NYSTATIN 100% · PowderANDA062613-001 · Discontinued
- NYSTATIN 500,000 UNITS · TabletANDA062838-001 · Discontinued



